<unk>  is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. It was synthesized in order to create an antibiotic with a broader spectrum. It is often grouped with the second-generation cephalosporins.<unk>  requires a prescription and as of 2010 is sold under the brand name Mefoxin by Bioniche Pharma, LLC. The generic version of<unk>  is known as<unk>  sodium.
Cefoxitin
Meropenem
Resistin
Vancomycin
Ertapenem
Imipenem
Piperacillin
Rifamycin